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Abstract
Objective-To evaluate the role of leuco-
cytes in free radical production in
patients with depressed or normal ejec-
tion fraction undergoing coronary bypass.
Design-Two randomised control trials.
Setting-Tertiary care centre.
Patients and interventions-In the first
study, 22 patients with ejection fractions
of < 40% received blood cardioplegic
reperfusion with (n = 11) or without (n =
11) leucocyte depletion. In the second
study, 22 patients with ejection fractions
> 45% received either leucocyte depleted
(n = 11) or blood cardioplegia (n = 11).
Main outcome measures-Glutathione,
hypoxanthine, and lipid peroxidation
products were measured in coronary
sinus blood and plasma before aortic
cross clamping and at 0, 15, and 30 min-
utes after unclamping. Haemodynamic
variables and creatine kinase MB isoen-
zymes were monitored on the first post-
operative day. Comparison between
treatments was performed on difference
(A) between measurements at time 0 and
at baseline, and on slopes obtained by fit-
ting measurements after unclamping with
a linear regression model.
Results-At unclamping no difference in
A for plasma glutathione redox ratio (oxi-
dised/total glutathione, %) was observed
between treated and control groups with
low ejection fraction (A = 16 (SD 8.39)
and 24 (7.0) redox ratio %, respectively).
Baseline value recovery rate (redox ratio
%/olmin) was significantly faster in treated
v control patients (slope -0-912 (0.380) v
-0-158 (0.200), P < 0 005, respectively).
Cardiac index showed a trend to greater
improvement in the treated group (slope
0-04 (0.03) v 0 003 (0.002) Iminlm'/h, P <
0-02, treated v controls, respectively). In
patients with normal ejection fraction,
leucocyte depletion did not result in sig-
nificant improvement v controls.
Conclusions-Leucocyte depletion seems
to provide benefit only in patients with
left ventricular dysfunction.
(Heart 1997;77:449-455)
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In the past 10 years, a great deal of interest has
been focused on the role of leucocytes in gen-
erating reperfusion injury in the myocardium.'
Activated leucocytes accumulate in reperfused
myocardium and are believed to be responsi-
ble for capillary plugging, release of arachi-
donic acid metabolites, activation of comp-
lement, and production of oxygen free radicals
by the NADPH (reduced nicotinamide ade-
nine dinucleotide phosphate) oxidase path-
way.2A Leucocyte depletion induced by
pharmacological agents, antineutrophil anti-
bodies, and leucocyte filters has been shown to
be protective in animal models.2 4 However,
there is little information about the influence
of leucocyte depletion of cardioplegic reper-
fusate on myocardial metabolism and free rad-
ical activity during cardiac surgery in humans.
Reactive oxygen species are produced phys-
iologically in cells during redox reactions,
including respiration, but their production
may be increased in pathological conditions.6
Oxygen free radicals can be cytotoxic by
attacking unsaturated fatty acids, starting lipid
peroxidation of membranes, and promoting
oxidation of protein sulphydryl groups and
polypeptide chain scission. Excessive pro-
duction of free radicals beyond the antioxidant
capacity triggers an oxidant stress to the cell.
Glutathione, one of the most abundant intra-
cellular antioxidants, acts as cosubstrate for
glutathione peroxidase, or as free radical
species and lipid peroxide scavenger, with oxi-
dation to the disulphide form. Furthermore,
the increase in oxidised glutathione and the
inability of the cells to produce reducing
equivalents impairs the enzymatic system (glu-
tathione reductase) required for the reduction
to reduced glutathione (GSH), thereby
enhancing the loss of GSH. Thus the ratio of
the oxidised form to total glutathione (redox
ratio) plays an important role in the regulation
of the redox state of the cells.8 Oxidised glu-
tathione is actively transported across the cell
membrane to plasma and, together with the
redox ratio, may be considered a reliable index
of oxidative stress.9 10 A well known result of
free radical action is peroxidation of mem-
brane polyunsaturated fatty acids, which ulti-
mately results in the production of toxic
aldehydes such as malondialdehyde and 4-
hydroxynonenal. These can react with critical
targets, including proteins, forming fluores-
cent Schiff bases that are easily detectable.6 "
Although lipid peroxidation and antioxidants
are non-specific indices of ischaemia-reperfu-
sion injury and can be altered by different
processes (such as inflammation), enhanced
lipid peroxidation products together with
depression of antioxidants is widely accepted
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as a reliable index of oxygen free radical activ-
ity 9 10 12
The aim of our study was to test the
hypothesis that leucocyte depletion could
improve myocardial protection during revas-
cularisation in patients with a low and
preserved ejection fraction undergoing cardio-
pulmonary bypass. To do this we evaluated
changes in glutathione status, fluorescent
products of lipid peroxidation, and hypoxan-
thine in coronary plasma. Because erythro-
cytes are a natural reserve of antioxidants,
determinations were also carried out on whole
blood samples.
Methods
PATIENTS
The research was structured in two indepen-
dent studies on patients undergoing elective
myocardial revascularisation. In the first study
22 patients with an ejection fraction < 40%
(assessed by a first pass radionuclide angiogra-
phy) were randomly assigned to receive either
blood cardioplegia with leucocyte depletion of
cardioplegic reperfusate (LD, n = 11) or
blood cardioplegia (LC, control group, n =
11). In the second study 22 subjects with an
ejection fraction >o 45% were randomly allo-
cated into two groups: 11 patients received
leucocyte depleted blood cardioplegia (ND);
and 11 patients were treated with blood car-
dioplegia (NC, control group). Subjects with
other associated cardiac disease, acute
myocardial infarction, or cardiogenic shock, as
well as patients undergoing additional surgical
procedures (valve replacement, aneurysmec-
tomy), were not entered into the protocol. On
the basis of a positron emission tomography
(PET) study, patients without viable myo-
cardium were also excluded. Antianginal med-
ication was continued until the day of surgery.
All patients were operated on by the same sur-
gical staff. Preoperative data are presented in
the table.
The protocol was approved by the ethics
committee of our institute and all patients
gave informed consent to the study.
SURGICAL PROCEDURE
A standard cardiopulmonary bypass technique
was used throughout the study. The same
Clinical data. Continuous variables are expressed as medians,
variables are expressed asfrequency
roller pump (Stockert Instruments, Germany),
membrane oxygenator (Compact D703,
Dideco, Mirandola, Italy), in-line filter, and
cardioplegic prime (Ringer lactate solution
1500 ml, mannitol 250 ml, and Emagel
100 ml) were used. In addition to the cannula-
tions for bypass, the retrograde cannula (retro-
plegia coronary sinus cannula, 14F, Research
Medical, Midvale, Utah, USA) and the ante-
grade cannula (aortic root cannula, DLP Inc,
Grand Rapids, Michigan, USA) were placed
in the coronary sinus and the aortic root,
respectively. Moderate normovolaemic haemo-
dilution (packed cell volume: 20-25%) and
moderate hypothermia (28-30°C) were used.
Myocardial revascularisation was achieved,
when possible, with bilateral internal mam-
mary arteries plus saphenous vein graft. In
patients with a low ejection fraction, ventricular
venting was performed by the right superior
pulmonary vein. Myocardial protection was
achieved by antegrade-retrograde blood car-
dioplegia according to Buckberg's protocol.'3 14
Blood cardioplegia was given by a "Buckberg-
Shiley Plus" circuit (Shiley Incorporated,
Irvine, California, USA) which supplied oxy-
genated blood and crystalloid cardioplegia
with a 4:1 ratio. The cardioplegic delivery time
was divided between antegrade in aorta and
retrograde in coronary sinus. Cardiac arrest
was induced with warm (37°C) blood sub-
strate enriched cardioplegic solution for five
minutes, followed by three minutes of cold
induction. Cardioplegic maintenance was sim-
ilarly assured every 20 minutes for two min-
utes in both antegrade and retrograde
directions in separate ratios. Before release of
aortic cross clamping, warm blood cardio-
plegic reperfusion (37°C) was given in an
antegrade-retrograde manner and through the
venous grafts under controlled conditions with
a non-beating and empty heart for three min-
utes (1-5 minutes antegrade and 1.5 minutes
retrograde).'3 In order to maintain good coro-
nary perfusion at the end of cardiopulmonary
bypass, mean arterial pressure was maintained
between 70 and 90 mm Hg by using inotropic
drugs (dopamine) or nitrate infusion.
Cardioplegic reperfusion was leucocyte
depleted by using four filters (Leukoseize 2,
Dideco, Mirandola, Italy) in parallel on the
cardioplegic line; leucocyte depletion of car-
5th and 95th centiles are given in parentheses; discrete
Group LD Group LC Group ND Group NC
Patients (n) 11 11 11 11
Age (years) 63 (49 to 73) 67 (56 to 74) 65 (54 to 76) 61 (50 to 70)
CCS class, II/IVl/N 0/7/4 0/8/3 4/3/4 5/4/2
Ejection fraction (%) 35 (27 to 40) 34 (26 to 40) 57 (45 to 66) 54 (45 to 68)
Diseased vessels, 1/2/3/4/5 (n) 0/1/8/2/0 0/2/4/4/1 1/2/3/4/1 1/2/5/2/1
Distal anastomoses, 1/2/3/4/5 (n) 0/1/8/1/1 0/4/2/4/1 1/1/3/4/2 1/1/5/2/2
Proximal anastomoses, 0/1/2 (n) 3/7/1 3/5/3 3/4/4 4/5/2
Bypass time (min) 158 (91 to 188) 160 (85 to 185) 128 (104 to 168) 136 (64 to 158)
Cross clamp time (min) 87 (60 to 115) 90 (52 to 115) 77 (60 to 92) 82 (25 to 116)
Inotrope use (> 5,ug/kg/min) (n) 7/11 8/11 1/11 1/11
Intra-aortic balloon pumping (n) 2/11 2/11 0/11 0/11
Creatine kinase MB,5 h 26 (16 to 40) 27 (11 to 57) 16 (1 to 21) 12 (5 to 35)
Creatine kinase MB, 10 h 27 (11 to 49) 27 (21 to 74) 24 (10 to 33) 14 (5 to 32)
Creatine kinase MB, 15 h 20 (5 to 73) 19 (10 to 48) 9 (7 to 20) 8 (4 to 10)
CCS class, Canadian Cardiovascular Society system of grading angina; LC, controls with ejection fraction < 40%; LD, treated
patients with ejection fraction < 40%; NC, controls with ejection fraction > 45%; ND, treated patients with ejection fraction
> 45%. Creatine kinase MB was expressed as nmol/ml in LD and LC group, as IU/1 for ND and ND groups (LC and LD,
controls and treated with low ejection fraction; NC and ND, controls and treated with normal ejection fraction).
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dioplegia implied the use of six leucocyte fil-
ters. The efficacy of the depletion technique
was assessed by the leucocyte count at the out-
put of the filters (Coulter Counter, model S
Plus IV & V, Instrumentation Laboratory
SpA, Milan, Italy). Depletion was considered
acceptable when the leucocyte count was less
than 150 cells/mm3.
BIOCHEMICAL EVALUATIONS
For biochemical measurements blood was
withdrawn in cooled heparinised tubes from
coronary sinus through the retroplegic cannula
before aortic cross clamping, and 0, 15, and
30 minutes after aortic unclamping, and
placed in an ice bath.
Glutathione
Glutathione was measured in blood and
plasma immediately after sampling by reversed
phase high performance liquid chromatogra-
phy (HPLC) with pre-column derivatisation
as previously described.'5 Total and total free
glutathione concentrations were determined
after reduction of disulphides with dithiothre-
itol; for measurements of the oxidised form
the treatment with dithiothreitol was preceded
by reaction with N-ethylmaleimide. Samples
were automatically derivatised with o-phtha-
laldehyde just before injection. Glutathione
disulphide concentration was always expressed
as GSH equivalents. Glutathione redox ratio
was calculated as the ratio of oxidised to total
glutathione and expressed as a percentage.
Hypoxanthine
Immediately after sampling, blood (100 Ml) or
plasma (250 gl) were deproteinised with
500 MI of 6% perchloric acid, neutralised by
addition of sodium bicarbonate, and stored at
- 20°C before HPLC analysis.'6 The mobile
phase consisted of 0.1 mol/l KH2P04, pH 6-0
(buffer A), and buffer A containing 10%
methanol (buffer B). Column (LiChroCart
RP18, 250 x 4 mm, Merck, Darmstadt,
Germany) was eluted at 1 ml/min with buffer
A for 15 minutes, then buffer B was increased
to 100% in one minute and held for five min-
utes; the initial conditions were restored in five
minutes.
Lipid peroxidation
Fluorescent adducts resulting from interaction
of terminal aldehydes with amino groups of
proteins were determined in plasma according
to the method of Ward et al." Fluorescence
was monitored on a LS-3 spectrofluorimeter
(Perkin-Elmer, Norwalk, Connecticut, USA)
previously calibrated with quinine sulphate.
Blood and plasma measurements were cor-
rected for haemoglobin content or packed cell
volume to exclude any dilution effect.'7
HAEMODYNAMIC AND CLINICAL DATA
Standard haemodynamic measurements includ-
ing heart rate, mean arterial pressure, left and
right arterial pressure, pulmonary wedge pres-
sure, cardiac output by thermodilution, and
the derived cardiac index, were taken in the
operating room before stemotomy and at the
end of surgery, and in the intensive care unit at
5, 10, 15, 20, and 25 hours after aortic
unclamping. Myocardial isoenzymes of crea-
tine kinase were determined by an immunoen-
zymatic assay (Stratus, Baxter Diagnostics Inc,
Deerfield, Illinois, USA) on peripheral blood
5, 10, and 15 hours after surgery. The use of
inotropic agents (dopamine 5 jug/kg/min) or
intra-aortic balloon pumping, electrocardio-
graphic alteration (as myocardial infarctions
evidenced by new Q waves) were also consid-
ered in the first postoperative day.
STATISTICAL ANALYSIS
Statistical analysis was performed by compar-
ing treated subjects v controls in the first trial
(LD v LC), and in the second trial (ND v
NC).
We focused on two aspects: first we calcu-
lated the difference between the measurement
at time 0 (immediately after the clamp period)
and the measurement at baseline for each sub-
ject; then we fitted a linear regression model
on the measurements at 0, 15, and 30 minutes
after unclamping in each subject. The same
analysis was performed for cardiac index and
creatine kinase MB by fitting measurements
taken before sternotomy, at the end of surgery,
and at 5, 10, 15, 20, and 25 hours after
surgery. Differences between groups (treated v
controls), both in A and in slopes, were
assessed by the Wilcoxon rank test. Statistical
significance was assumed at P < 0 05. All
analyses were performed using the SAS statisti-
cal package for personal computers (SAS
Institute, Cary, North Carolina, USA). Slopes
and A are expressed as mean (SD).
Results
Clinical information is summarised in the
table. No significant differences were found in
any of the preoperative data between treated
and the respective control group. No patients
died or had electrocardiographic or enzyme
changes suggestive for a perioperative myocar-
dial infarct.
GLUTATHIONE
In patients with a low ejection fraction the cal-
culated A for plasma free oxidised glutathione
did not differ significantly between treatments
(fig 1A) and a similar trend to normalisation
during the following 30 minutes (slope =
-0 053 (0.1 1) v -0x076 (0 10) imolImin,
LD v LC) was shown in the two groups (fig
2A). By contrast, leucocyte depletion
improved the recovery rate of the redox ratio
% to preischaemic levels (slope = -0-912
(0 380) v -0-158 (0 200) %/min, P < 0 005,
LD v LC) (fig 2B), while A at unclamping was
similar (A = 16 (8 4)% v 24 (7 0)%, LD v
LC, respectively) (fig 1B). In patients with a
normal ejection fraction, even though the A
showed an increment in plasma oxidised
glutathione (fig 1A), there was no marked
alteration in the redox ratio % at unclamping
(fig 1B), the value remaining unchanged over
the following 30 minutes (fig 2B). During the
same period oxidised glutathione normalised
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Figure 1 Differences (A)
calculated as (time 0,
baseline) measurements in
coronary plasma for:
(A) oxidised glutathione;
(B) glutathione redox ratio
%; (C) hypoxanthine;
(D) fluorescent products.
Data are means, error bars
= SD. LC and LD,
controls and treated with
low ejection fraction; NC
and ND, controls and
treated with normal
ejection fraction.
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in both groups (slope = -0 035 (0 030) v
-0-046 (0 060) imol/l/min, ND v NC) (fig
2A). ND patients never showed significant dif-
ferences compared with controls.
In coronary blood from the LD and LC
groups, oxidised glutathione increased after
cross clamp removal (A = 0-251 (0-162) v
0-214 (0 200) Mmol/l, LD v LC), with a similar
recovery to pre-bypass values (slope: - 0-006
(0 006) imol/l/min for both groups). As a
result, heart reperfusion after unclamping was
associated with an increment in erythrocyte
redox ratio % (A = 4-02 (2 27)% v 3-54
(3-39)%, LD v LC), followed by a similar
Figure 2 (A) Oxidised
glutathione (GSSG +
soluble mixed disulphides)
concentration; (B)
glutathione redox ratio %
(oxidisedltotal glutathione
%) in coronary sinus
plasma. * LDpatients;
0 LC patients; A ND
patients; A NC patients
(LC and LD, controls and
treated with low ejection
fraction; NC and ND,
controls and treated with
normal ejection fraction.
Data are expressed as
means, error bars = SD.
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recovery to pre-ischaemic conditions (slope =
-0-12 (0 09) v -0 10 (0 10), %/min LD v
LC). In ND and NC groups, A for oxidised
glutathione did not show sustained oxidation
(A = 0 03 (0-03) v 0 04 (0 04) pmol/l, respec-
tively) so that the redox ratio % was only
slightly altered (A = 0-34 (0-29)% v 0-25
(0-37)%, ND v NC).
HYPOXANTHINE
Hypoxanthine rose in all groups at unclamp-
ing, both in blood (A = 13-5 (10A4) v 14-3
(6 38) imol/l, LD v LC; A = 17-2 (11-4) v
13-9 (6 97) imol/l, ND v NC) and in plasma
(fig 1C). After 30 minutes from cross clamp
removal, blood and plasma concentrations (fig
3A) were still altered in all groups. Plasma
hypoxanthine was highly variable among ND
patients, thus accounting for the high levels
observed in the time curve reported in fig 3A
for this group.
LIPID PEROXIDATION
Initial values of lipid peroxidation index
ranged from 71 to 251 UF/ml in patients with a
low ejection fraction and from 42 to 106
UF/ml in those with a normal ejection frac-
tion. Values of A for fluorescent products were
similar in plasma of all groups (fig 1D), and in
the ensuing 30 minute period the values did
not decrease (fig 3B). Although no significant
difference between treated and controls was
found, levels of fluorescent products were
always lower in the LD than in the LC group
(fig 3B).
HAEMODYNAMIC AND CLINICAL DATA
The use of inotropic agents (dopamine more
than 5 ig/kg/min) or intra-aortic balloon
pumping was similar in all groups. Creatine
kinase MB increased after bypass, reaching a
maximum value after 10 hours, with the same
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Figure 3 (A)
Hypoxanthine
concentration; (B)
fluorescent products of lipid
peroxidation during
cardiopulmonary bypass in
coronary sinus plasma.
0 LD patients; 0 LC
patients; A ND patients;
A NC patients (LC and
LD, controls and treated
with low ejection fraction;
NC and ND, controls and
treated with normal
ejection fraction. Data are
expressed as means, error
bars = SD.
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Figure 4 Cardiac index
during and after coronary
artery bypass grafting
(CABG). BAS, before
aortic cross clamping;
END, end of coronary
artery bypass grafting.
0 LD patients; 0 LC
patients; A ND patients;
A NC patients (LC and
LD, controls and treated
with low ejection fraction;
NC and ND, controls and
treated with normal
ejection fraction. Data are
expressed as means, error
bars = SD.
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trend in patients with low and normal ejection
fractions. No differences were observed
between treated patients and controls (table).
In the LD group, the cardiac index
improved linearly until it reached a value of
3.99 (0 57) 1/min/m2 at 25 hours, the calcu-
lated slope of the curve being significantly dif-
ferent from the respective control group (0 04
(0-03) v 0003 (0.002) l/min/m2/h, P < 0'02,
LD v LC) (fig 4). Both treated and control
patients with a normal ejection fraction
showed a rapid improvement in cardiac index
after the operation (slope = 0 03 (0-02) I/min/
m2/h for both ND and NC), with no difference
between treatments.
Discussion
Reperfusion of the ischaemic myocardium is
clinically encountered in the thrombolytic
treatment of myocardial infarction, coronary
angioplasty, bypass surgery, and cardiac trans-
plantation. Although beneficial, uncontrolled
reperfusion is associated with tissue damage
and functional alteration. Rigid control of
reperfusion conditions and reperfusate com-
position has been shown to be essential
for salvaging the previously ischaemic myo-
cardium.'8
Oxygen free radicals, produced during car-
diopulmonary bypass, are widely implicated as
the main agents of ischaemia-reperfusion
injury. 101719-21 The increased free radical activity
in the myocardium results from a reperfusion
induced burst in production. This burst over-
whelms the capacity of defence mechanisms,
because a depletion of radical scavengers
occurs during ischaemia. Leucocytes, particu-
larly neutrophils, are recognised as one of the
major extracellular sources of oxidant species,
although not the only one.22 2' The initial step in
neutrophil accumulation involves interaction
between leucocytes and vascular endothelial
cells because of their large size, lack of
deformability, and the increased expression of
neutrophil binding sites.24-26 Once bound, neu-
trophils may be activated by various pathways,
including superoxide production by xanthine
oxidase, complement activation, and leuko-
triene B4 production.27-29 Neutrophil activa-
tion results in greatly enhanced oxygen uptake
by cells and in the production of reactive oxy-
gen species.'0 These considerations provide a
rationale for the use of leucocyte depleted
blood cardioplegia during bypass surgery.
Previous work has emphasised the value of
leucocyte depletion in the long term isolated
heart, such as in transplantation,2" 32 but to
the best of our knowledge no data are available
on the benefits provided over short ischaemic
periods in humans. Since patients with left
ventricular dysfunction are considered to be at
high perioperative risk and require efficient
myocardial protection, in the first study we
aimed to evaluate the efficacy of leucocyte
depletion of cardioplegic reperfusate in this
kind of subject. The efficacy of the treatment
prompted us to evaluate leucocyte depletion in
patients with preserved ejection fraction.
Moreover, since during bypass, brief
ischaemic periods alternate with short reperfu-
sion, we decided to extend the leucocyte
depletion to all phases of cardioplegia.
In patients with low ejection fraction a sus-
tained increment in oxidant species, associated
with an increased formation of lipid peroxida-
tion products, suggests the occurrence of
oxidative damage. Leucocyte depletion of car-
dioplegic reperfusion enhanced myocardial
protection by promoting a fast recovery of the
plasma redox ratio to preischaemic levels and
by lowering fluorescent product formation at
unclamping. The efficacy of leucocyte deple-
tion was confirmed by the better time response
of the cardiac index. We did not find signifi-
cant differences in inotropic requirements,
probably because of the low dose inotropic
support routinely used to wean patients from
bypass. The study on patients with normal
ejection fraction provided evidence of an
increase in plasma oxidised glutathione and in
fluorescent products of lipid peroxidation.
However, these patients were able to balance
production of oxidised glutathione, since no
appreciable variation in redox ratio was
observed over time in blood and plasma. In
this class of subjects, leucocyte depletion did
453
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not seem able to provide additional benefits to
blood cardioplegia, even though the postopera-
tive cardiac index appeared to be improved by
the treatment.
The higher values of plasma hypoxanthine
when leucocyte depletion was performed (LD
and ND groups) may support the protective
effect of the treatment, since the role of xan-
thine oxidase in generating oxygen free radi-
cals in reperfused organs is well known.3"34
The slower hypoxanthine catabolism may be
related to the lack of histamine release from
leucocytes, which is responsible for xanthine
oxidase activation.35
Our data on plasma glutathione are only
apparently at variance with those published by
Ferrari and co-workers in 1990,10 since they
achieved myocardial protection by using the St
Thomas' Hospital cardioplegic solution, while
we used blood cardioplegia. Blood cardiople-
gia has been shown to be superior to crystal-
loid cardioplegia36 because blood blends
antioxidant benefits with its ability to increase
oxygen delivery, prevents ischaemic injury,
and limits reperfusion damage. In addition
and as described by Buckberg,'6 before aortic
unclamping we performed a brief period of
controlled blood cardioplegic reperfusion,
which limits myocardial damage. Curello et al
have recently suggested that sequestration of
leucocytes by the heart during the early phase
of reperfusion is unlikely to be related to the
rate of oxygen free radical production, since
they were not able to observe local neutrophil
activation in patients with a normal ejection
fraction.'7 We found that in patients with low
ejection fraction leucocyte depletion of cardio-
plegic reperfusate improves recovery to preis-
chaemic glutathione redox status in the early
phase of reperfusion and improves the
mechanical function of the heart in the 24
hours following bypass. These results suggest
that leucocytes play a major role in oxidative
stress, although activation of the leucocytes is
probably not the initiating event.
Although the aim of our study was to assess
the efficacy of leucocyte depletion, from our
data the response to the ischaemic insult
seems to be linked to the baseline ejection
fraction. It may be supposed that hearts with
left ventricular dysfunction are more suscepti-
ble to free radical oxidative damage than nor-
mal hearts. However, we cannot rule out the
possibility that the lack of benefit observed in
patients with a good ejection fraction may be
related to a less sustained generation of oxi-
dants than in patients with a poor ejection
fraction. To gain a better understanding of the
relation between intracellular oxidative
processes during bypass surgery and heart
function, determination of antioxidants in
myocardial biopsies is now in progress.
In conclusion, leucocyte depletion may be
advisable in patients with poor heart function,
while it appears to provide no benefit in
patients with a normal ejection fraction over
the routinely used blood cardioplegia.
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